Notice Number: NOT-OD-07-005

Key Dates
Release Date:  October 13, 2006
Effective Date:  October 13, 2006

Issued by
National Institutes of Health (NIH) (http://www.nih.gov)
National Human Genome Research Institute (NHGRI) (http://www.nhgri.nih.gov)
National Institute of Mental Health (NIMH) (http://www.nimh.nih.gov)

This notice is to clarify that resubmission (amended) applications must be submitted when appropriate for the following recently released funding opportunity announcements:

Near-Term Technology Development for Genome Sequencing (R01)
RFA-HG-06-015

Near-Term Technology Development for Genome Sequencing (R21)
RFA-HG-06-016

Near-Term Technology Development for Genome Sequencing (R21/R33)
RFA-HG-06-017

Near-Term Technology Development for Genome Sequencing (SBIR [R43/R44])
RFA-HG-06-018

Near-Term Technology Development for Genome Sequencing (STTR [R41/R42])
RFA-HG-06-019

Revolutionary Genome Sequencing Technologies – The $1000 Genome (R01)
RFA-HG-06-020

Revolutionary Genome Sequencing Technologies - The $1000 Genome (R21)
RFA-HG-06-021

Revolutionary Genome Sequencing Technologies – The $1000 Genome (R21/R33)
RFA-HG-06-022

Revolutionary Genome Sequencing Technologies – The $1000 Genome (SBIR [R43/R44])
RFA-HG-06-023

Revolutionary Genome Sequencing Technologies – The $1000 Genome (STTR [R41/R42])
RFA-HG-06-024

Applicants may not simultaneously submit identical/essentially identical applications under more than one HHS funding opportunity announcement.  If an application did not receive an award as a result of the previous Request for Applications, an application on the same topic that is being submitted to a corresponding reissued FOA mentioned above, must be prepared as a resubmission/amended version.  Such an application must include an Introduction and mark the text to show changes.  If a new application has been submitted for a standard submission date and the applicant would prefer to respond to the reissued Request for Applications, then the new application must be withdrawn prior to the submission of a resubmission application.

The following additional review criteria will be used when evaluating the scientific and technical merit of a resubmitted application:

1. Are the responses to comments from the previous scientific review group adequate?
2. Are the improvements in the resubmission application appropriate?

Inquiry

Inquiries regarding this Notice should be directed to:

Jeffery A. Schloss, Ph.D.
Division of Extramural Research
National Human Genome Research Institute, NIH
5635 Fishers Lane, Suite 4076
Bethesda, MD 20892-9305
Telephone:  (301) 496-7531
Email: schlossj@exchange.nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files.